30results about How to "Reduce plasma viscosity" patented technology

An application of the Chinese medicine 'Superfine Tongxinluo' in relaxing the vascular endothelial injury caused by atherosclerosis, decreasing the cardiac infarction range after AMI reperfusion, preventing hyperlipemia and atherosclerosis, and treating arteria coronaria spasm, pile, thromboangiitis obliterans, platelet coagulation, etc is disclosed.

A Chinese medicine for treating senile dementia, dizziness, disturbed sleep, etc is prepared from fleece flower root, lotus leaf, cistanche, earthworm and uniflower swisscentaury root through respective extracting, and proportional mixing.

The invention discloses a vertigo treatment drug compound Yuntong and its preparation process and quality control method. The bulk drugs include: scutellaria, radix bupleuri, Rhizoma Pinellinae Praeparata, Codonopsis pilosula, liquorice, tangerine peel, rhizoma alismatis, bighead atractylodes rhizome, poria, Gastrodia elata, chrysanthemum, Uncaria tomentosa, acorus gramineus, panax notoginseng, leech, and radix puerariae. The preparation method comprises: conducting ethanol reflux extraction on the bulk drugs; concentrating the extracted solution, carrying out drying, crushing and sieving, adding soluble starch and microcrystalline cellulose, mixing the materials evenly, performing granulating and capsule filling, thus obtaining the compound Yuntong capsule. The invention also relates to establishment of a standard fingerprint spectrum, establishment of a test sample fingerprint spectrum and comparison of the two spectrums. The fingerprint spectrum of the drug shows 17 main chromatographic peaks at the place of 283nm, and the chemical structure of one chromatographic peak therein can be determined as baicalin, and baicalin can be chosen as an index component to perform content determination. The method has the advantages of good precision, stability and reproducibility, can be used for quality control of the drug and preparations provided by the invention, and provides reference for clinical application choice.

The invention relates to pseudo-ginseng dragon blood preparation, which is characterized in that: the pseudo-ginseng dragon blood preparation comprises the following medicinal raw materials by weight portion: 300 to 400 grams of pseudo-ginseng powder and 200 to 280 grams of dragon blood; auxiliary materials are added into the raw materials to prepare 1,000 granules; and the preparation is tablets, capsules and pills, wherein, the pseudo-ginseng powder and the dragon blood are 300 mesh hyperfine powder. The pseudo-ginseng dragon blood preparation takes pseudo-ginseng as a main medicine and the dragon blood as an auxiliary material with the two medicines mutually coordinated, has good comprehensives effects of treating and preventing hypertension, hyperlipemia and cardiovascular and cerebrovascular diseases, promoting blood circulation and improving the immunologic function of an organism, and particularly can protect the intestine and the stomach and effectively avoid damage of the intestine and the stomach due to long-term use of the pseudo-ginseng. The pseudo-ginseng dragon blood preparation is convenient in taking and good in mouthfeel, is safe and reliable, and can be used for a long time.

The invention provides a traditional Chinese medicine composition for treating diabetic nephropathy. The traditional Chinese medicine composition comprises the following components of Ramulus euonymi, trichosanthes root, Panax pseudo-ginseng var. notoginseng and rhizoma coptidis according to the proportion by weight of 1-3:1-2:1-2:1-3. When being taken, the four medicines are respectively smashed and mixed, decocted by a traditional Chinese medicine decocting method and filtered, and the filtered liquid medicine is taken.

A Chinese medicine in the form of oral liquid, syrup, capsule, particle, tablet, or pill for treating and preventing coronary heart disease, pnenmocardial disease, cerebroanoxia and angina pectoris is prepared from 3 Chinese-medicinal materials including rhodiola root, wolfberry fruit, etc. Its preparing process is also disclosed.

In order to meet the clinical needs, better treat cardiovascular and cerebrovascular diseases and improve the health level of the people, the invention provides a new pharmaceutical composition for the treatment of the cardiovascular and cerebrovascular diseases and its preparation method, and the pharmaceutical composition is mainly prepared from hawthorn leaves, allium macrostemon, polygonatum and rhizoma polygonati, and produces previously unimagined effects on the treatment of the cardiovascular and cerebrovascular diseases.

The invention relates to a traditional Chinese medicine composition for reducing blood fat and blood pressure, which comprises the following raw materials in parts by weight: 5-25 parts of parasitic loranthus, 15-22 parts of polygonum multiflorum, 16-24 parts of sealwort, 20-24 parts of hawthorn, 12-17 parts of cassia seed, 12-15 parts of uncaria, 15-20 parts of prunella spike, 11-18 parts of motherwort fruit, 13-16 parts of root of red-rooted salvia, 8-12 parts of achyranthes root, 12-17 parts of baikal skullcap root, 8-12 parts of chrysanthemum, 20-30 parts of gastrodia tuber, 12-17 parts of siegesbeckia herb, 2-4 parts of radix notoginseng and 12-19 parts of tuber fleeceflower stem. The composition applies the traditional Chinese medicine theory, starts from integrity, achieves compatibility of medicines, and has the efficacies of tonifying the middle-jiao with circulation, nourishing without grease, strengthening the body without astringency, promoting circulation without scattering, nourishing the liver and kidney simultaneously, activating stagnancy and expelling turbid urine, promoting blood circulation and relaxing veins, thereby achieving the effects of reducing the blood fat and blood pressure.

The invention discloses an antithrombotic medicine. The antithrombotic medicine is prepared by evenly mixing, by weight, 0.3-99.7 parts of fructus cannabis extract and 99.7-0.3 part of industrial cannabinoid. Experiments show that the medicine has a remarkable antithrombotic effect, can remarkably suppress formation of thrombus in the bodies of rats, has a remarkable suppressing effect on platelet aggregation of rats, can remarkably delay the blood coagulation time of rats, can reduce the whole blood viscosity, plasma viscosity and packed cell volume of rats, has a better acting effect than cannabidiol, and has good application prospects.

The invention discloses a cannula packer containing citrate. The cannula packer containing citrate is used for packing a venous indwelling cannula, which can effectively solve the problems of catheter occlusion, blood return, stagnating, heat pain, phlebitis and phlebothrombosis formation caused by the venous indwelling cannula, the treatment effect is further improved, aching feeling of a patient is greatly relieved, and pain of the patient is reduced. It is found that citrate has excellent functions of removing and resisting stasis, can effectively reduce whole blood viscosity and plasma viscosity in acute blood stasis and reduce blood sedimentation and hematokrit and has good treatment effects of removing and resisting stasis. Citrate has excellent anti-inflammatory and pain relieving actions, can synergistically promote inflammatory factors in serum of diabetic nephropathy patients receiving hematodialysis treatment and improves the treatment effect.

The invention relates to a traditional Chinese medicine composition for treating coronary heart disease and a preparation method thereof. The traditional Chinese medicine composition is composed of 35-53 parts of blood jellyfish, 35-53 parts of liquid gum, and 95-125 parts of salvia miltiorrhiza in the following weight proportions; and Oral preparations of traditional Chinese medicine made according to a certain extraction and preparation process and with pharmaceutically acceptable excipients. The traditional Chinese medicine composition of the invention has the characteristics of simple and feasible preparation process, safe and effective, obvious pharmacological effect and clinical test effect.

The invention discloses an intervertebral disc traditional Chinese medicine composition and a preparation method thereof. The preparation method comprises the following steps: S1, adding semen persicae, rhizoma chuanxiong, radix paeoniae rubra, radix salviae miltiorrhizae, radix bupleuri, rhizoma cyperi, radix codonopsis, Chinese angelica root, radix platycodi, trogopterus dung and myrrha into a container, adding 5 to 15 volume times of distilled water, soaking for 5 to 6 hours, and filtering, thus obtaining a first soaking solution and filter residue; then adding 2 to 5 volume times of distilled water in the filter residue, soaking for 2 to 3 hours, and filtering, thus obtaining a second soaking solution and filter residue; merging the first soaking solution and the second soaking solution, and boiling for 4 to 6 hours, thus obtaining a first concentrated solution; S2, mixing the filter residue with radix et rhizoma rhei, ramulus cinnamomi, radix glycyrrhizae preparata, natrii sulfas, fructus aurantii, fructus evodiae and rhizoma seu radix notopterygii, then adding sesame oil, and extracting, thus obtaining volatile oil; S3, merging the first concentrated solution obtained in the step S1 with the volatile oil obtained in the step S2, adding 2 to 6 volume times of water, and decocting, thus obtaining an extracting solution; S4, adding the extracting solution obtained in the step S3 in a stirring machine, fully mixing, transferring a mixed solution to a distillation barrel for distilling, and finally forming unguent.

The invention relates to a blood glucose lowering tea product, which specifically comprises bitter gourd, ganoderma lucidum and fructus momordicae. According to the present invention, the bitter gourd, the ganoderma lucidum and the fructus momordicae in the formula have significant treatment effects for high blood glucose, and the effects are synergetic and the treatment effect is excellent after the components are combined; a variety of biologically active ingredients benefitting for human body in the bitter gourd, the ganoderma lucidum and the fructus momordicae are moderately retained; and the palatability of the tea product is substantially improved by using the sweet taste of the fructus momordicae, the teat product can instantly become a health tea beverage after infusion with boiling water, and the infused tea beverage is easy to drink, is suitable for people with high blood glucose, has effects of body building, physical fitness, immunity enhancing, aging delaying, face nourishing and beautifying , and is the high-grade health care tea.

The invention relates to a traditional Chinese medicine composition for treating a coronary heart disease and a preparation method of the traditional Chinese medicine composition. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 35-53 parts of resina draconis, 35-53 parts of resina liquidamberis and 95-125 parts of salviae miltiorrhizae; and the raw materials and pharmaceutically acceptable auxiliary materials are prepared into a traditional Chinese medicinal oral preparation according to a certain extraction preparation technology. The traditional Chinese medicine composition provided by the invention has the characteristics of being simple and feasible in preparation technology, safe, effective and obvious in pharmacological and pharmacodynamic functions and clinical test effect.

An application of the Chinese medicine 'Superfine Tongxinluo' in relaxing the vascular endothelial injury caused by atherosclerosis, decreasing the cardiac infarction range after AMI reperfusion, preventing hyperlipemia and atherosclerosis, and treating arteria coronaria spasm, pile, thromboangiitis obliterans, platelet coagulation, etc is disclosed.

The invention relates to a preparation method and new purpose of glycyrrhiza uralensis Fisch. (Glycyrrhiza uralensis Fisch.) or glycyrrhiza glabra L.(Glycyrrhiza glabra L.) or glycyrrhiza inflata Bat.(Glycyrrhiza inflata Bat.) stem and leaf total flavonoids. Specifically, for the first time, the inventor of the invention finds that the stem and leaf total flavonoids of the glycyrrhiza uralensis Fisch. or the glycyrrhiza glabra L. or the glycyrrhiza inflata Bat. have good effect of restraining lipases, and have favorable preventing and treating effects on hyperlipaemia and obesity. The stem and leaf total flavonoids of the glycyrrhiza uralensis Fisch. or the glycyrrhiza glabra L. or the glycyrrhiza inflata Bat. can be used for preparing medicines and health-care foods for preventing and treating the hyperlipaemia and the obesity.

The invention discloses application of a general anesthesia element to preparation of antithrombotic drugs. The general anesthesia element is formed by evenly mixing, by weight, 0.3-99.7 parts of industrial hemp fructus cannabis extract and 0.3-99.7 parts of industrial hemp cannabis elements. The drug composition general anesthesia element has an obvious antithrombotic effect. Experiments show that the general anesthesia element can obviously restrain formation of thrombus in rat bodies, has an obvious restraining effect on rat platelet aggregation, and can obviously prolong the mouse blood clotting time, reduce the whole blood viscosity, the plasma viscosity and hematokrit of rats, and the effects of the general anesthesia element are superior to those of hemp diphenol. The general anesthesia element has good application prospects.

The present invention relates to preparation process and application of medicine for treating cerebral embolism, cerebral angiospasm and other ischemic encephalopathy and cerebral arteriosclerosis. The medicine has the functions of promoting blood circulation to disperse blood clots, relieving spasm and pain, strengthening cerebral and coronary artery. The medicine is prepared with kudzu vine root, ginkgo leaf and borneol, and through washing material, drying, mixing, crushing, ethanol extraction, concentrating extracted liquid, sucking filtering, spray drying, pelletizing and other steps.

The invention discloses a composition capable of increasing high-density lipoprotein. The composition comprises 20-30 parts by weight of hawthorn extract, 15-25 parts by weight of kudzuvine root extract, 10-20 parts by weight of semen cassiae extract, 10-20 parts by weight of peach seed extract, 10-20 parts by weight of onion extract, 10-20 parts by weight of jujube extract, 5-10 parts by weight of salvia miltiorrhiza extract, 5-10 parts by weight of ganoderma lucidum extract, 5-10 parts by weight of radix codonopsis extract, 5-10 pars by weight of Sichuan lovage rhizome extact and 5-10 parts by weight of panax notoginseng extract. The composition can be taken as a medicine, can also be taken as a health care food, or can be added into foods to be taken as a medicined diet, can obviously improve content of high-density lipoprotein if taken for a long term and have no obvious adverse effect or side effect.

A Chinese medicine for preventing high-viscosity blood and thrombus is prepared from 5 Chinese-medicinal materials including astragalus root, red sage root, Chinese angelica root, Chuan-xiong rhizome, etc. Its advantages are high curative effect, quickly taking its effect and no by-effect.

The invention discloses a nine-ingredient gardenia jasminoides flos carthami liniment for treating acute soft tissue injury and a preparation method thereof, and relates to the technical field of medicines. The nine-ingredient gardenia jasminoides flos carthami liniment is prepared from 700 to 1300 parts of fructus gardeniae, 700 to 1300 parts of flos carthami, 350 to 650 parts of radix clematidis, 350 to 650 parts of radix angelicae sinensis, 210 to 390 parts of ground beeltle, 210 to 390 parts of borneol, 70 to 130 parts of frankincense, 70 to 130 parts of myrrh and 70 to 130 parts of dragon's blood. The preparation method comprises the following steps: each dose being 1 g, weighing the medicinal materials except borneol according to the prescription dosage ratio, uniformly mixing, crushing, sieving, soaking in 70-90% ethanol with the volume being 4-6 times that of the medicinal materials for 48 hours according to the ratio of 1g of the medicinal materials to 1ml of a solvent, slowly percolating, collecting initial percolation liquid for later use, adding 70-90% ethanol with the volume being 4-6 times that of the medicinal materials, slowly percolating, concentrating the percolation liquid under reduced pressure until the percolation liquid is free of alcohol smell, merging with the initial percolation liquid, and adding the crushed borneol according to the prescription dosage ratio, adding a proper amount of 95% ethanol to uniformly disperse, adding pure water to adjust the total amount of the solution to be 6.21-6.61 times of the total amount of the medicinal materials, uniformly shaking, and subpackaging to obtain the traditional Chinese medicine composition. The nine-ingredient gardenia jasminoides flos carthami liniment has good swelling and pain relieving effects on acute soft tissue injury.

The present invention relates to Chinese medicine preparation, and is especially the preparation process and application of Chinese medicine preparation for treating vocal nodules and polyp of vocal cord. The preparation process of the present invention is stable, practical, high material utilizing rate and high effective component extracting rate, and the Chinese medicine preparation has high chlorogenic acid content. The Chinese medicine preparation has the functions of promoting blood circulation to disperse blood clots, lowering blood viscosity, lowering fibrinogen content and platelet adhesiveness, and inhibiting proliferation of granulation tissue.

The invention discloses a use of a Liuwei dihuang preparation in preparations of treatment drugs for treating patients after heart stent surgeries.

A traditional Chinese medicine preparation for reducing viscosity and preventing thrombosis, which is prepared from the following raw materials: 10-100 grams of astragalus, 15-40 grams of salvia miltiorrhiza, 10-30 grams of angelica, 10-30 grams of chuanxiong and 15-45 grams of curcuma. 10-100 grams of astragalus, 15-40 grams of salvia miltiorrhiza, 10-30 grams of angelica, 10-30 grams of Chuanxiong, 15-45 grams of turmeric, 10-30 grams of Chuanxiang and 10 grams of skullcap ~30 grams. The advantage is that it has the functions of promoting blood circulation and removing blood stasis, moving qi and removing stagnation, dredging meridians and dredging collaterals, preventing stroke and other cardiovascular and cerebrovascular diseases caused by high blood viscosity, and does not require other auxiliary treatments. It is not only safe, reliable, simple and convenient , Strong practicability, no side effects, low price, short course of treatment, quick effect, and remarkable curative effect.

The present invention provides a Chuanxiong rhizome volatile oil soft capsule and its preparation method and use. The Chuanxiong rhizome volatile oil described in the invention is prepared by a carbon dioxide supercritical extraction method, the contend of the effective component Chuanxiong rhizome phthalide in the Chuanxiong rhizome volatile oil reaches the medicinal standard, and the quality is stable and can be controlled. The invention also provides the use of the Chuanxiong rhizome volatile oil soft capsule for preparing the medicine for curing cerebral apoplexy during recovery period.

A Chinese medicine for treating senile dementia, dizziness, disturbed sleep, etc is prepared from fleece flower root, lotus leaf, cistanche, earthworm and uniflower swisscentaury root through respective extracting, and proportional mixing.

The invention belongs to the field of traditional Chinese medicines and relates to a traditional Chinese medicine composition for treating pure obesity and a preparation method thereof. The existing medicine for treating the pure obesity is poor in treatment effect, and therefore the invention provides the traditional Chinese medicine composition for treating the pure obesity. The traditional Chinese medicine composition is prepared from the following traditional Chinese medicine ingredients in parts by weight: 45-60 parts of figwort flower picrorhiza rhizome, 5.5-7 parts of weeping forsythia capsule, 30-40 parts of rhubarb, 25-30 parts of turmeric, 30-35 parts of oriental waterplantain rhizome, 85-90 parts of rhizoma corydalis, 15-20 parts of cattail pollen, 12-15 parts of light yellow sophora root, 5-10 parts of common cephalanoplos herb, 9-15 parts of purpleflower crotalarla herb, 10-15 parts of root of woodland beakchervil, 6-9 parts of dwarf lilyturf tuber and 10-15 parts of areca seed. The traditional Chinese medicine composition can modify the clinical symptoms of a pure obesity suffer, corrects the hormone level of the pure obesity suffer so as to be suitable for popularizing and using clinically.

The invention provides application of purslane total flavonoids to preparation of hypoglycemic drugs, and belongs to the field of modern medicine. For the preparation of medicaments for the treatment of type II diabetes, the purslane total flavonoids are safe for oral administration; and the purslane total flavonoids are formed together with a solid excipient in the preparation of a medicament for treating diseases of type II diabetes. The purslane total flavonoids can decrease the blood glucose level of animals in a wistar rat hyperglycemia model, have significant differences compared with the model group, and can reduce whole blood high shear ratio viscosity, whole blood low shear ratio viscosity and plasma viscosity in blood rheology, have statistical significance. The purslane total flavonoids can be used for the preparation of antidiabetic drugs.

The invention relates to a preparation method and application of a medicine for cerebral embolism, cerebral vasospasm and other ischemic encephalopathy and cerebral arteriosclerosis. The original name is Jengke Capsule. Currently on the market, there are drugs for the treatment of cerebral embolism, cerebral vasospasm and other ischemic encephalopathy and cerebral arteriosclerosis diseases, symptomatic treatment. The purpose of the present invention is to develop a method for promoting blood circulation and removing stasis, dredging channels and relieving collaterals, relieving spasm and relieving pain, and enhancing brain and coronary blood flow in the treatment of cerebral embolism, cerebral vasospasm and other ischemic encephalopathy and cerebral arteriosclerosis. Flow, preparation method and application of medicine for treating ischemic encephalopathy and cerebral arteriosclerosis. The technical scheme of the present invention: medicine kudzu root gram, ginkgo leaf, borneol, preparation method, after selection, washing, drying, mixing, crushing, adding ethanol, extracting liquid, concentrating, standing, suction filtration, spray drying, granulation, etc. The process obtains the drug. Advantages have the functions of promoting blood circulation and removing blood stasis, dredging channels and relaxing collaterals, and are clinically used for cerebral thrombosis and thrombotic cerebral infarction.